Results 71 to 80 of about 84,355 (327)

Engineering antibodies with cancer‐associated binding sites

open access: yesBMEMat, EarlyView.
This review describes antibodies that perform direct/indirect roles in cancer treatment by binding to effective targets and discusses how antibodies kill tumors and modulate tumor microenvironment through these targets. The classification of expression systems for antibody production is summarized to guide appropriate selection based on different ...
Yinqi Tian   +4 more
wiley   +1 more source

Fatal Cutaneous γ/δ T-Cell Lymphoma with Central Nerve System Metastasis [PDF]

open access: yes, 2011
Cutaneous γ/δ T-cell lymphoma is an extremely rare and highly aggressive tumor that is often resistant to treatment, such as polychemotherapy and radiotherapy.
Kim, Kwang Ho   +5 more
core   +2 more sources

Unveiling the complexity of cellular senescence in cancers: From mechanism to therapeutic opportunities

open access: yesBMEMat, EarlyView.
This review highlights the complex roles of cellular senescence in cancer progression and suppression, discusses the mechanisms and regulatory pathways involved, and evaluates the efficacy of the “One‐Two punch” sequential treatment approach while addressing emerging challenges in this novel therapeutic strategy.
Qiuming Pan   +12 more
wiley   +1 more source

Primary cutaneous lymphoma of scalp in a child: a case report [PDF]

open access: yes, 2017
Cutaneous lymphomas are a heterogenous group of lymphoproliferative disorders with involvement of skin and form a separate group under Non-Hodgkin’s lymphoma.
Lakshmi, A. Bhagya, Sri, K. Satya
core   +2 more sources

Extranodal diffuse large B‐cell lymphoma: Clinical and molecular insights with survival outcomes from the multicenter EXPECT study

open access: yesCancer Communications, EarlyView.
Abstract Background Diffuse large B‐cell lymphoma (DLBCL) is the most common subtype of aggressive non‐Hodgkin's lymphoma with distinct clinical and molecular heterogeneity. DLBCL that arises in extranodal organs is particularly linked to poor prognosis. This study aimed to determine the clinical and molecular characteristics of extranodal involvement (
Si‐Yuan Chen   +46 more
wiley   +1 more source

Cutaneous T-cell lymphomas [PDF]

open access: yesAtlas of Genetics and Cytogenetics in Oncology and Haematology, 2011
These are peripheral T-cell tumours, usually expressing CD4 along with other T-cell markers. The CD30 molecule is expressed in a histologically distinct subset (vide infra). Classification: The WHO identifies some well-defined clinicopathological entities with distinct clinical behaviour. Indolent forms include mycosis fungoides, primary cutaneous CD30
Antonio Cuneo, Gianluigi Castoldi
openaire   +1 more source

Persistent varicella as the initial manifestation of systemic lymphoma [PDF]

open access: yes, 2008
Varicella is a common benign childhood disease that often presents in adolescents and adults in a more severe form. We report a previously healthy 50-year-old man who developed multiple necrotic cutaneous ulcers associated with fever, asthenia and ...
Ferreira, M.   +4 more
core  

Paraneoplastic pemphigus: insight into the autoimmune pathogenesis, clinical features and therapy [PDF]

open access: yes, 2017
Paraneoplastic pemphigus is a rare autoimmune skin disease that is always associated with a neoplasm. Usually, oral, skin, and mucosal lesions are the earliest manifestations shown by paraneoplastic pemphigus patients.
Andrea Ciofalo   +21 more
core   +2 more sources

Streamlining Vorinostat Synthesis: A Chemoenzymatic Continuous Flow Approach

open access: yesEuropean Journal of Organic Chemistry, EarlyView.
A chemoenzymatic protocol for the synthesis of histone deacetylase inhibitor vorinostat has been established. Immobilized lipase from C. antarctica (imm‐CaLB) allowed the functionalization of suberanoyl acid 1 and further conversion to vorinostat via ion‐exchange resin treatment.
Francesca Annunziata   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy